KDM1B and cancer: In a recent publication, Musella and colleagues elucidate that inadequate type I interferon (IFN-I) signaling in tumors undergoing immunogenic cell death (ICD) fosters the buildup of cancer stem cells (CSCs) through the activation of the epigenetic regulator lysine demethylase 1B (KDM1B).